Form EFFECT Alto Neuroscience, Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 20, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alto Neuroscience, Inc. (ANRO) Tops Q2 EPS by 10c
- transcosmos receives Special Award for Digital Utilization in JiIT's Best Customer Support of The Year 2026
- Alto Neuroscience Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share